Header Logo

Connection

Anthonet Koen to Vaccines, Synthetic

Back to Details
This is a "connection" page, showing publications Anthonet Koen has written about Vaccines, Synthetic.
Anthonet Koen
Connection Strength
0,059
Vaccines, Synthetic
  1. Immunogenicity and safety of SARS-CoV-2 recombinant spike protein vaccine in South African people living with and without HIV-1 infection: A phase 2 randomised trial. J Infect. 2024 Dec; 89(6):106285.
    View in: PubMed
    Score: 0,059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.